Shengtai Pharmaceutical, Inc. (SGTI.OB) Reports Fiscal 2010 Financial Results, Returns to Profit
Shengtai Pharmaceutical Inc. operates through its wholly owned subsidiary, Shengtai Holding Inc., to manufacture and distribute glucose and starch as pharmaceutical raw materials and other starch and glucose products in China. The company today reported its financial results for the 12 months ended June 30, 2010. Shengtai Pharmaceutical posted sales revenue for the fiscal year ended June 30, 2010, of $115.9 million, a 58-percent increase over sales revenue for fiscal 2009. The company attributes the increase in sales revenue to an increase in sales volume and selling prices. Net sales from exports for the fiscal year increased approximately 131 percent…